HomeATRA • NASDAQ
Follow
Atara Biotherapeutics Inc
Previous close
$0.60
Year range
$0.20 - $3.17
Market cap
60.78M USD
Avg Volume
2.76M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
.INX
0.00%
1.01%
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 2.14M | -52.05% |
Operating expense | 69.14M | 265.33% |
Net income | -69.80M | 17.00% |
Net profit margin | -3.26K | -73.11% |
Earnings per share | -0.66 | 19.51% |
EBITDA | -68.41M | 17.80% |
Effective tax rate | 0.03% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 102.41M | -61.41% |
Total assets | 188.79M | -48.74% |
Total liabilities | 239.63M | 32.24% |
Total equity | -50.84M | — |
Shares outstanding | 106.40M | — |
Price to book | -1.24 | — |
Return on assets | -79.97% | — |
Return on capital | -498.42% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -69.80M | 17.00% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2012
Headquarters
Website
Employees
308